| Polymerase chain reaction: the molecular microscope of residual disease |
| J Sklar |
|
JCO Sep 1 1991: 1521–1524.
[PDF]
|
 |
| Organ preservation in bladder carcinoma: a matter of selection |
| CJ Logothetis |
|
JCO Sep 1 1991: 1525–1526.
[PDF]
|
|
|
The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma |
| |
CG Price, J Meerabux, S Murtagh, FE Cotter, AZ Rohatiner, BD Young, and TA Lister |
| |
JCO Sep 1 1991: 1527–1532.
[Abstract]
[PDF]
|
|
|
Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy |
| |
CY Fung, WU Shipley, RH Young, PP Griffin, KM Convery, DS Kaufman, AF Althausen, NM Heney, and GR Prout, Jr |
| |
JCO Sep 1 1991: 1533–1542.
[Abstract]
[PDF]
|
|
|
Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group |
| |
M Rorth, GK Jacobsen, H von der Maase, EL Madsen, OS Nielsen, M Pedersen, and H Schultz |
| |
JCO Sep 1 1991: 1543–1548.
[Abstract]
[PDF]
|
|
|
Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma |
| |
A Harstrick, HJ Schmoll, H Wilke, CH Kohne-Wompner, M Stahl, C Schober, J Casper, L Bruderek, E Schmoll, and C Bokemeyer |
| |
JCO Sep 1 1991: 1549–1555.
[Abstract]
[PDF]
|
|
|
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia |
| |
P Fenaux, G Tertian, S Castaigne, H Tilly, G Leverger, H Guy, D Bordessoule, R Leblay, E Le Gall, and P Colombat |
| |
JCO Sep 1 1991: 1556–1561.
[Abstract]
[PDF]
|
|
|
A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia |
| |
CA Puccio, A Mittelman, SM Lichtman, RT Silver, DR Budman, T Ahmed, EJ Feldman, M Coleman, PM Arnold, and ZA Arlin |
| |
JCO Sep 1 1991: 1562–1569.
[Abstract]
[PDF]
|
|
|
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia |
| |
SJ Forman, GM Schmidt, AP Nademanee, MD Amylon, NJ Chao, JL Fahey, PN Konrad, KA Margolin, JC Niland, and MR O'Donnell |
| |
JCO Sep 1 1991: 1570–1574.
[Abstract]
[PDF]
|
|
|
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease |
| |
NJ Chao, AP Nademanee, GD Long, GM Schmidt, TA Donlon, P Parker, ML Slovak, LS Nagasawa, KG Blume, and SJ Forman |
| |
JCO Sep 1 1991: 1575–1579.
[Abstract]
[PDF]
|
|
|
Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function |
| |
EA Neuwelt, DL Goldman, SA Dahlborg, J Crossen, F Ramsey, S Roman-Goldstein, R Braziel, and B Dana |
| |
JCO Sep 1 1991: 1580–1590.
[Abstract]
[PDF]
|
|
|
Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study |
| |
MA Weiner, BG Leventhal, R Marcus, M Brecher, J Ternberg, FG Behm, A Cantor, M Wharam, and A Chauvenet |
| |
JCO Sep 1 1991: 1591–1598.
[Abstract]
[PDF]
|
|
|
Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988 |
| |
LC Bowman, ML Hancock, VM Santana, FA Hayes, L Kun, DM Parham, WL Furman, BN Rao, AA Green, and WM Crist |
| |
JCO Sep 1 1991: 1599–1608.
[Abstract]
[PDF]
|
|
|
Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatin |
| |
SD Huan, JC Yau, FR Dunphy, RO Wallerstein, K Dicke, V Spencer, CF LeMaistre, AB Deisseroth, GN Hortobagyi, and FA Holmes |
| |
JCO Sep 1 1991: 1609–1617.
[Abstract]
[PDF]
|
|
|
Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience |
| |
KS Albain, JJ Crowley, M LeBlanc, and RB Livingston |
| |
JCO Sep 1 1991: 1618–1626.
[Abstract]
[PDF]
|
|
|
Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study |
| |
E Bork, J Ersboll, P Dombernowsky, B Bergman, M Hansen, and HH Hansen |
| |
JCO Sep 1 1991: 1627–1631.
[Abstract]
[PDF]
|
|
|
Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer |
| |
N Murray, A Shah, D Osoba, R Page, H Karsai, C Grafton, K Goddard, R Fairey, and N Voss |
| |
JCO Sep 1 1991: 1632–1638.
[Abstract]
[PDF]
|
|
|
Small-cell carcinoma of the lung: derivation of a prognostic staging system |
| |
U Sagman, E Maki, WK Evans, D Warr, FA Shepherd, JP Sculier, R Haddad, D Payne, JF Pringle, and JL Yeoh |
| |
JCO Sep 1 1991: 1639–1649.
[Abstract]
[PDF]
|
|
|
Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study |
| |
PP Rosen, S Groshen, and DW Kinne |
| |
JCO Sep 1 1991: 1650–1661.
[Abstract]
[PDF]
|
|
|
Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome |
| |
A Recht, SE Come, RS Gelman, M Goldstein, S Tishler, SM Gore, AL Abner, FA Vicini, B Silver, and JL Connolly |
| |
JCO Sep 1 1991: 1662–1667.
[Abstract]
[PDF]
|
|
|
Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project |
| |
|
| |
JCO Sep 1 1991: 1668–1674.
[Abstract]
[PDF]
|
|
|
Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil |
| |
H Boussen, E Cvitkovic, JL Wendling, N Azli, M Bachouchi, R Mahjoubi, C Kalifa, P Wibault, G Schwaab, and JP Armand |
| |
JCO Sep 1 1991: 1675–1681.
[Abstract]
[PDF]
|
|
|
Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma |
| |
J Crown, ES Casper, J Botet, P Murray, and DP Kelsen |
| |
JCO Sep 1 1991: 1682–1686.
[Abstract]
[PDF]
|
|
|
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study |
| |
G Stoter, S Aamdal, S Rodenhuis, FJ Cleton, S Iacobelli, CR Franks, R Oskam, and E Shiloni |
| |
JCO Sep 1 1991: 1687–1691.
[Abstract]
[PDF]
|
|
|
Sequences of taxol and cisplatin: a phase I and pharmacologic study |
| |
EK Rowinsky, MR Gilbert, WP McGuire, DA Noe, LB Grochow, AA Forastiere, DS Ettinger, BG Lubejko, B Clark, and SE Sartorius |
| |
JCO Sep 1 1991: 1692–1703.
[Abstract]
[PDF]
|
|
|
Cardiac disturbances during the administration of taxol |
| |
EK Rowinsky, WP McGuire, T Guarnieri, JS Fisherman, MC Christian, and RC Donehower |
| |
JCO Sep 1 1991: 1704–1712.
[Abstract]
[PDF]
|
|
| Calculating dose intensity |
| AJ Coldman and CM Coppin |
|
JCO Sep 1 1991: 1713–1714.
[PDF]
|
|
| Levamisole and melanoma |
| MR Kurman |
|
JCO Sep 1 1991: 1714–1715.
[PDF]
|
|
| Dose-intensity analysis and randomized trials |
| G Heller and NK Cheung |
|
JCO Sep 1 1991: 1715–1716.
[PDF]
|
|
